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Abstract The aim of the study was to determine whether immunoreactivity to major histocompatibility complex (MHC) class II antigens studied by immunohistochemistry could be used reliably to define villitis lesions in placenta. Eighteen placental sections with villitis and 32 without, as determined in a careful observer reproducibility study, were immunolabeiled with a monoclonal antibody to monomorphic determinants of MHC class II antigens (CR3/43), using a standard avidin-biotin peroxidase technique. Placentas with villitis were found to express MHC class II antigens. However, some showed no immunoreactivity. Occasional villi unaffected by villitis, including those near placental infarcts, also expressed MHC class II antigens. The study therefore showed that immunohistochemistry cannot be used to define villitis of unknown aetiology. It the three pathologists in the observer reliability study using conventional light microscopy (results not illustrated). Immunoreactivity was seen in villi affected by villitis and in unaffected villi. However, villitis foci also showed absent immunostaining. The one negative case resulted because the relevant focus of villitis had cut through in the deeper immunostained section. Of the 32 cases thought not to have villitis by the pathologists, 17 showed MHC class II immunoreactivity of variable intensity. Some of the positivity was seen in areas adjacent to infarcts.
Discussion
Although differences in methodology may account partly for the differing results, this study does not confirm that MHC class II immunoreactivity labels for villitis exclusively. MHC class II immunoreactivity near to infarcts indicates activation of the resident stromal macrophages and confirms their role in scavenger functions. Immunoreactivity in non-villitis areas in cases diagnosed conventionally as villitis as well as in non-villitis cases suggests immunopathology, but the pathogenesis is unclear and could be the result of infection or allogeneic recognition reactions. The possibility that villitis is a marker of a maternal immune attack on the fetal allograft' is supported by the finding of maternal inflammatory cells in VUA lesions.3 However, the alternative possibility of a fetal response to foreign antigens, maternal or infectious, should not be discounted. Firstly, MHC class II immunoreactivity by syncytiotrophoblast is analogous to aberrant expression by epithelium in graft versus host disease9; secondly, the majority of the intravillous inflammation is fetal in origin, the proportion of maternal cells in affected villi ranging between 30% and 54%3; and finally, in this study MHC class II immunoreactivity was detected in non-inflamed areas. Without double labelling experiments, it could not be determined whether the labelling in non-inflamed areas was present in syncytiotrophoblast and the resident stromal macrophages or confined to the latter. Labelling by syncytiotrophoblast could be the result of inducement by cytokines in the microenvironment and can lead to influx of maternal inflammatory cells and a reactive activation ofresident fetal macrophages. Labelling by macrophages alone, on the other hand, could be due to activation by an as yet unidentified agent and can lead to induction of syncytiotrophoblast MHC class II labelling. Further studies will be necessary to determine the sequence and primary site of MHC class II expression in non-inflamed villi as this may help to explain the initiating factors in the causation of villitis and in our understanding ofits clinical significance. We have not excluded the hypothesis that villitis is an immunopathological lesion; we have merely found that immunopathology, if defined by MHC class II immunoreactivity, is present also in villi showing no histological evidence of villitis.
This study also questions the assumption that immunohistochemistry provides an objectivity that conventional histological methods lack. VUA is defined initially by conventional light microscopy but there can be significant intraobserver and interobserver unreliability in its diagnosis, one reason being the difficulty in distinguishing between stromal hypercellularity of the resident macrophages and true inflammation. MHC class II immunoreactivity by villitis cases led to a putative specific marker for villitis. Immunohistochemistry could then conceivably assume a precedent role over conventional light microscopy in defining the lesion. This is a paradigm of the chicken and the egg: how should the diagnosis be made and which criteria take priority? Although immunohistochemistry is being used increasingly as an aid to histological diagnosis and to define pathological lesions, cellular phenotype, and histogenesis, a dilemma can arise when there is conflict between the light microsocopy and immunohistochemistry diagnoses.'0 Unfortunately, attempts to resolve this using decision analysis and probability calculations may not apply always as illustrated by this study. 
